Financial News
Articles published by Genelux Corporation
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
August 14, 2024
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
July 30, 2024
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer
November 27, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Reports Third Quarter 2023 Financial Results and Provides General Business Updates
November 14, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 14, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
September 07, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Announces New Chief Financial Officer
August 28, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Reports Second Quarter 2023 Financial Results and Provides General Business Updates
August 14, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2023
August 02, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Strengthens Senior Management and Clinical Team with Promotions and New Hires
July 20, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Set to Join the Russell 3000® and Russell 2000® Indexes Effective June 26, 2023
June 22, 2023
From Genelux Corporation
Via GlobeNewswire
Tickers
GNLX
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
![](https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png)
Genelux Corporation Announces Pricing of Initial Public Offering
January 25, 2023
From Genelux Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.